title: New Insulins, Biosimilars, and Insulin Therapy.
authors.affiliation: 1 Diabetes-Zentrum für Kinder and Jugendliche, Kinder- und Jugendkrankenhaus AUF DER BULT , Hannover, Germany .
authors.forename: Thomas
authors.initials: T
authors.lastname: Danne
authors.affiliation: 2 Science & Co GmbH , Düsseldorf, Germany .
authors.forename: Lutz
authors.initials: L
authors.lastname: Heinemann
authors.forename: Jan
authors.initials: J
authors.lastname: Bolinder
mesh_terms: D000293:Adolescent; D000328:Adult; D059451:Biosimilar Pharmaceuticals / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D048909:Diabetes Complications / Q000139:chemically induced / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D061385:Insulins / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D059451:Biosimilar Pharmaceuticals; D015507:Drugs, Investigational; D007004:Hypoglycemic Agents; D061385:Insulins